Cynata Therapeutics Competitors and Similar CompaniesClear all

Cynata Therapeutics's competitors and similar companies include Longeveron, Solid State Pharma and Integra.

	Cynata Therapeutics Cynata Therapeutics is a stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.	Longeveron Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases.	Solid State Pharma Solid State Pharma is a solid-state science and crystallization engineering company.	Integra Integra is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions.
Founding Date	Founding Date 2011	Founding Date 2014	Founding Date 2014	Founding Date 1989
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare bioengineering biotech life sciences pharma	Tags Healthcare bioengineering biotech life sciences pharma	Tags Healthcare bioengineering biotech pharma	Tags Healthcare bioengineering biotech pharma
Locations	Locations Carlton, AU HQ Cremorne, AU Hawthorn, AU	Locations Miami, US HQ	Locations Halifax, CA HQ	Locations Jerusalem, IL HQ
Employees	Employees N/A	Employees 259% increase	Employees 32	Employees 7
Valuation ($)	Valuation ($) 33.8 m	Valuation ($) 31.4 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $396k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $1.9m (FY, 2025)	Gross profit $803k (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($9.4m) (FY, 2025)	Net income ($22.7m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 14.1m	Total funding raised $ 9m	Total funding raised N/A	Total funding raised $ 28m